A Review of Recent Clinical Trials in the Treatment of Alzheimer's Dementia
- 1 March 1987
- journal article
- review article
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 17 (3) , 178-191
- https://doi.org/10.3928/0048-5713-19870301-09
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Physostigmine effects in Alzheimer's disease: Relationship to dementia severityLife Sciences, 1986
- Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's diseaseAnnals of Neurology, 1983
- GM Allotypes in Membranous NephropathyNew England Journal of Medicine, 1983
- Effects of Naloxone in Senile Dementia: A Double-Blind TrialNew England Journal of Medicine, 1983
- Memory Enhancement with Oral Physostigmine in Alzheimer's DiseaseNew England Journal of Medicine, 1983
- Enkephalins interfere with acquisition of an active avoidance responseLife Sciences, 1980
- Naloxone enhancement of memoryBehavioral and Neural Biology, 1979
- Naloxone alters locomotion and interaction with environmental stimuliLife Sciences, 1979
- Passive avoidance learning in Lesch-Nyhan disease: Effect of 1-desamino-8-arginine-vasopressinLife Sciences, 1979